Berenberg says GSK 'undervalued' but pipeline underwhelms
18th Oct 2021 09:26
(Sharecast News) - Analysts at Berenberg reduced their target price for shares of GlaxoSmithKline from 1,625.0p to 1,540.0p, but stood by their 'buy' recommendation on the shares, pointing out that the company's exit from its Consumer healthcare division was now closer and arguing that the stock remained "fundamentally undervalued".
Read moreGlaxo's consumer arm drawing interest from private equity - report
12th Oct 2021 12:29
(Sharecast News) - GlaxoSmithKline shares topped the FTSE 100 index on Tuesday following a report that the pharmaceuticals giant's consumer unit was drawing interest from private equity firms in what could lead to the biggest buyout of all time.
Read moreGlaxo unveils plans for £120m consumer healhcare HQ ahead of split
11th Oct 2021 14:42
(Sharecast News) - GlaxoSmithKline on Monday unveiled plans for a new £120m base for its consumer healthcare operations as it prepares to split into two listed firms.
Read moreGSK, SK Bioscience to start Phase 3 Covid vaccine trial
31st Aug 2021 07:02
(Sharecast News) - South Korea's SK Bioscience and the UK's GlaxoSmithKline on Tuesday said they would start a phase 3 clinical study of SK's Covid-19 vaccine candidate combined with GSK's pandemic vaccine booster
Read moreGSK, SK Bioscience to start Phase 3 Covid vaccine trial
31st Aug 2021 07:02
(Sharecast News) - South Korea's SK Bioscience and the UK's GlaxoSmithKline on Tuesday said they would start a phase 3 clinical study of SK's Covid-19 vaccine candidate combined with GSK's pandemic vaccine booster
Read moreWednesday broker round-up
18th Aug 2021 11:47
(Sharecast News) - Empiric Student: Berenberg downgrades to hold with 100.0p target price.
Read moreTuesday broker round-up
17th Aug 2021 14:02
(Sharecast News) - Future: ShoreCap stays at buy; Deutsche Bank keeps at buy and raises target price from 3,802.0p to 4,138.0p.
Read moreSunday newspaper round-up: Meggitt, GlaxoSmithKline, Luxury goods
15th Aug 2021 17:08
(Sharecast News) - Ministers must be prepared to block a takeover of Meggitt if any bidder tries to buy it without giving binding commitments on investment and jobs, the FTSE 250 aerospace and defence manufacturer's chairman warned this weekend. Sir Nigel Rudd said that while "clearly, price is important", any new owner would need to give Meggitt and the government undertakings, including to keep the company's headquarters in Coventry and maintain R&D spending. - Sunday Times
Read moreGSK and Vir Biotechnology to supply EU with Covid-19 treatment
28th Jul 2021 12:32
(Sharecast News) - GlaxoSmithKline has inked a joint procurement deal with Brussels for its Covid-19 treatment Sotrovimab together with its partner Vir Biotechnology.
Read moreGlaxoSmithKline Q2 profits, revenue jump
28th Jul 2021 12:09
(Sharecast News) - GlaxoSmithKline said on Wednesday that it expects full-year earnings to be towards the top end of its guidance range as it reported a jump in second-quarter profit and revenues amid a recovery in the vaccines business.
Read moreGSK appoints McNamara as CEO designate of consumer healthcare company
22nd Jul 2021 15:19
(Sharecast News) - GlaxoSmithKline has appointed Brian McNamara, the chief executive of its consumer healthcare division, as CEO designate of the new, listed consumer healthcare company that will be spun off from the group next year.
Read moreGSK announces positive results for treatment of anaemia in CDK patients
16th Jul 2021 13:42
(Sharecast News) - GlaxoSmithKline announced positive headline results from studies into its treatment of patients suffering from anaemia due to chronic kidney disease, Daprodustat.
Read moreWednesday broker round-up
7th Jul 2021 14:03
(Sharecast News) - WM Morrison: Berenberg downgrades to hold with a target price of 254p.
Read moreElliott calls for leadership review at GSK
1st Jul 2021 09:45
(Sharecast News) - Elliott Advisors has renewed pressure on the board of GlaxoSmithKline by calling for new directors and a review of whether chief executive Emma Walmsley should lead the company after it spins off its consumer arm.
Read moreThursday broker round-up
24th Jun 2021 14:13
(Sharecast News) - BP: HSBC downgrades to hold with a target price of 360p.
Read more